Summary of Former Genentech Scientists and Employees

Termination of the DR6 Drug Discovery Program

Genentech's decision to terminate the DR6 drug discovery program marked the end of many years of challenging and often frustrating research. The program had been a source of hope for scientists who were working towards finding a treatment for Alzheimer's disease.

Differences in Results and Conclusions

Upon the publication of the recently co-authored papers, the scientific community began discussing how the results and conclusions differed from those reported in the 2009 Nature paper. The differences in various aspects were noted and analyzed.

Disheartened Scientists

Many scientists who had worked on the DR6 drug discovery program were disheartened by its termination. They had invested significant time and effort into the project, hoping that it would lead to a breakthrough in Alzheimer's disease treatment. The disappointment felt by these scientists was palpable.

Summary of the Papers Submitted to the Journal of Neuroscience in 2013 and Published in 2014

The papers submitted by Dr. Tessier-Lavigne and his team focused on neuroscience. The specific details of the research and the findings are not mentioned in the given context.

Lack of Evidence of Investigation by RRC

The paper states that there is no evidence to suggest that the RRC conducted any investigation into fraud, fabrication, or other misconduct related to the 2009 Nature paper or the research leading to it. The RRC is not an investigative body and does not have the authority or mandate to conduct such investigations. Therefore, it is not surprising that no evidence of an investigation was found.

Lack of Complaints Received

The paper also highlights that there is no record or evidence to suggest that the company's anonymous complaint hotline, Legal Department, or Healthcare Compliance Office ever received a complaint regarding the 2009 Nature paper or the research leading to it. This suggests that there were no formal complaints made regarding any misconduct related to the paper or the research.

Date of Publication: Not specified

Publication source

See the PDF from which this article has been generated:

PDF source url: https://www.gene.com/download/pdf/Findings-of-2023-Genentech-Review-of-2009-Nature-Paper-and-Related-Research.pdf